These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 15979325)

  • 21. Impact of human leucocyte antigen mismatch on graft-versus-host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donors.
    Teshima T; Matsuo K; Matsue K; Kawano F; Taniguchi S; Hara M; Hatanaka K; Tanimoto M; Harada M; Nakao S; Abe Y; Wake A; Eto T; Takemoto Y; Imamura M; Takahashi S; Ishida Y; Kanda Y; Kasai M; Takaue Y
    Br J Haematol; 2005 Aug; 130(4):575-87. PubMed ID: 16098073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mini-BEAM and autologous hematopoietic stem-cell transplant for treatment of post-transplant lymphoproliferative disorders.
    Komrokji RS; Oliva JL; Zand M; Felgar R; Abboud CN
    Am J Hematol; 2005 Jul; 79(3):211-5. PubMed ID: 15981226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation.
    Uderzo C; Bonanomi S; Busca A; Renoldi M; Ferrari P; Iacobelli M; Morreale G; Lanino E; Annaloro C; Volpe AD; Alessandrino P; Longoni D; Locatelli F; Sangalli H; Rovelli A
    Transplantation; 2006 Sep; 82(5):638-44. PubMed ID: 16969286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Visual, auditory, sensory, and motor impairments in long-term survivors of hematopoietic stem cell transplantation performed in childhood: results from the Bone Marrow Transplant Survivor study.
    Gurney JG; Ness KK; Rosenthal J; Forman SJ; Bhatia S; Baker KS
    Cancer; 2006 Mar; 106(6):1402-8. PubMed ID: 16453335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of HLA mismatch, splenectomy and recipient Epstein-Barr virus seronegativity as risk factors in post-transplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation.
    Sundin M; Le Blanc K; Ringdén O; Barkholt L; Omazic B; Lergin C; Levitsky V; Remberger M
    Haematologica; 2006 Aug; 91(8):1059-67. PubMed ID: 16885046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging immunology of stem cell transplantation.
    DeMeyer ES
    Semin Oncol Nurs; 2009 May; 25(2):100-4. PubMed ID: 19411012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hematopoietic transplantation from adult unrelated donors as treatment for acute myeloid leukemia.
    Sierra J; Martino R; Sánchez B; Piñana JL; Valcárcel D; Brunet S
    Bone Marrow Transplant; 2008 Mar; 41(5):425-37. PubMed ID: 18209727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonmyeloablative stem cell transplantation and cell therapy for malignant and non-malignant diseases.
    Resnick IB; Shapira MY; Slavin S
    Transpl Immunol; 2005 Aug; 14(3-4):207-19. PubMed ID: 15982565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparable long-term survival after bone marrow versus peripheral blood progenitor cell transplantation from matched unrelated donors in children with hematologic malignancies.
    Meisel R; Laws HJ; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Schmitz M; Fischer J; Göbel U; Enczmann J; Dilloo D
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1338-45. PubMed ID: 17950920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pure red-cell aplasia following major and bi-directional ABO-incompatible allogeneic stem-cell transplantation: recovery of donor-derived erythropoiesis after long-term treatment using different therapeutic strategies.
    Helbig G; Stella-Holowiecka B; Wojnar J; Krawczyk M; Krzemien S; Wojciechowska-Sadus M; Markiewicz M; Wylezol I; Kopera M; Holowiecki J
    Ann Hematol; 2007 Sep; 86(9):677-83. PubMed ID: 17486341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Allogeneic hematopoietic stem cell transplantation].
    Mohty M
    Rev Prat; 2008 Dec; 58(19):2111-22. PubMed ID: 19213539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of hereditary blood diseases by hematopoietic stem cell allografts].
    Fischer A
    Rev Infirm; 2002 Dec; (86):22-3. PubMed ID: 12630224
    [No Abstract]   [Full Text] [Related]  

  • 33. Engraftment syndrome after nonmyeloablative allogeneic hematopoietic stem cell transplantation: incidence and effects on survival.
    Gorak E; Geller N; Srinivasan R; Espinoza-Delgado I; Donohue T; Barrett AJ; Suffredini A; Childs R
    Biol Blood Marrow Transplant; 2005 Jul; 11(7):542-50. PubMed ID: 15983554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Umbilical cord blood as a source of stem cells].
    Bojanić I; Golubić Cepulić B
    Acta Med Croatica; 2006 Jun; 60(3):215-25. PubMed ID: 16933834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and Cell Therapy.
    Yakoub-Agha I; Mesnil F; Kuentz M; Boiron JM; Ifrah N; Milpied N; Chehata S; Esperou H; Vernant JP; Michallet M; Buzyn A; Gratecos N; Cahn JY; Bourhis JH; Chir Z; Raffoux C; Socié G; Golmard JL; Jouet JP;
    J Clin Oncol; 2006 Dec; 24(36):5695-702. PubMed ID: 17116940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Donor cell reaction to OKT3 as predictor of chronic graft-vs-host disease in hematopoietic stem cell recipients.
    Lindemann M; Ottinger HD; Elmaagacli AH; Trenschel R; Rebmann V; Beelen DW; Grosse-Wilde H
    Exp Hematol; 2006 Dec; 34(12):1753-8. PubMed ID: 17157173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for acute graft-versus-host disease grades II-IV after reduced intensity conditioning allogeneic stem cell transplantation with unrelated donors: a single centre study.
    Remberger M; Mattsson J; Hassan Z; Karlsson N; LeBlanc K; Omazic B; Okas M; Sairafi D; Ringdén O
    Bone Marrow Transplant; 2008 Feb; 41(4):399-405. PubMed ID: 17982493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epstein-Barr virus-associated lymphoproliferative disease after allogeneic haematopoietic stem cell transplantation: molecular monitoring and early treatment of high-risk patients.
    Meijer E; Cornelissen JJ
    Curr Opin Hematol; 2008 Nov; 15(6):576-85. PubMed ID: 18832928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-6 and IL-10 promoter gene polymorphisms of patients and donors of allogeneic sibling hematopoietic stem cell transplants associate with the risk of acute graft-versus-host disease.
    Karabon L; Wysoczanska B; Bogunia-Kubik K; Suchnicki K; Lange A
    Hum Immunol; 2005 Jun; 66(6):700-10. PubMed ID: 15993715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hematopoietic growth factors including keratinocyte growth factor in allogeneic and autologous stem cell transplantation.
    Seggewiss R; Einsele H
    Semin Hematol; 2007 Jul; 44(3):203-11. PubMed ID: 17631184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.